Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis

Pihong Li,1,* Qiaolin Wu,2,* Yihan Sun,1,* Xiaoyu Pan,1 Yifan Han,1 Bing Ye,1 Yinlong Zhang,1 Jianda Dong,1 Zhouci Zheng1 1Departments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Departments of Anesthesiolog...

Full description

Bibliographic Details
Main Authors: Li P, Wu Q, Sun Y, Pan X, Han Y, Ye B, Zhang Y, Dong J, Zheng Z
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/downregulation-of-cdh16-in-papillary-thyroid-cancer-and-its-potential--peer-reviewed-article-CMAR
_version_ 1811330475087626240
author Li P
Wu Q
Sun Y
Pan X
Han Y
Ye B
Zhang Y
Dong J
Zheng Z
author_facet Li P
Wu Q
Sun Y
Pan X
Han Y
Ye B
Zhang Y
Dong J
Zheng Z
author_sort Li P
collection DOAJ
description Pihong Li,1,* Qiaolin Wu,2,* Yihan Sun,1,* Xiaoyu Pan,1 Yifan Han,1 Bing Ye,1 Yinlong Zhang,1 Jianda Dong,1 Zhouci Zheng1 1Departments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Departments of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianda Dong; Zhouci ZhengDepartments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaEmail necksurgery@126.com; 424505514@qq.comObjective: Thyroid cancer has the highest prevalence among the cancer types that affect the endocrine system; however, its molecular mechanisms are not yet determined. Cadherin-16 (CDH16) plays an important role in the tumorigenesis of human cancers, but its influence on papillary thyroid cancer (PTC) is poorly investigated. This study aimed to explore the role of CDH16 in PTC.Methods: We performed quantitative real-time polymerase chain reaction to investigate CDH16 expression in PTC. The clinical significance of CDH16 expression in PTC was then evaluated using The Cancer Genome Atlas (TCGA) database. Bioinformatics analysis was also conducted to determine the potential molecular mechanisms of CDH16.Results: CDH16 was remarkably downregulated in PTC tumors compared with that in corresponding normal thyroid tissues in the local and TCGA cohorts. This downregulation was associated with unfavorable clinicopathological features, including histological type, high tumor stage, aggressive lymph node metastasis (LNM), and advanced clinical stage. In addition, logistic analyses revealed that the reduced expression of CDH16 can aggravate the risk of LNM in PTC. Bioinformatics analysis indicated that the co-expressed CDH16 genes mainly participated in signaling the cancer-related pathways.Conclusion: CDH16 is involved in PTC progression and acts as an LNM-related gene in PTC.Keywords: CDH16, papillary thyroid cancer, lymph node metastasis, co-expression, mechanism
first_indexed 2024-04-13T16:02:26Z
format Article
id doaj.art-b4d82d7c8a894fdfa2b83214f2f47004
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-04-13T16:02:26Z
publishDate 2019-12-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-b4d82d7c8a894fdfa2b83214f2f470042022-12-22T02:40:30ZengDove Medical PressCancer Management and Research1179-13222019-12-01Volume 11107191072950664Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico AnalysisLi PWu QSun YPan XHan YYe BZhang YDong JZheng ZPihong Li,1,* Qiaolin Wu,2,* Yihan Sun,1,* Xiaoyu Pan,1 Yifan Han,1 Bing Ye,1 Yinlong Zhang,1 Jianda Dong,1 Zhouci Zheng1 1Departments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Departments of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianda Dong; Zhouci ZhengDepartments of Neck Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaEmail necksurgery@126.com; 424505514@qq.comObjective: Thyroid cancer has the highest prevalence among the cancer types that affect the endocrine system; however, its molecular mechanisms are not yet determined. Cadherin-16 (CDH16) plays an important role in the tumorigenesis of human cancers, but its influence on papillary thyroid cancer (PTC) is poorly investigated. This study aimed to explore the role of CDH16 in PTC.Methods: We performed quantitative real-time polymerase chain reaction to investigate CDH16 expression in PTC. The clinical significance of CDH16 expression in PTC was then evaluated using The Cancer Genome Atlas (TCGA) database. Bioinformatics analysis was also conducted to determine the potential molecular mechanisms of CDH16.Results: CDH16 was remarkably downregulated in PTC tumors compared with that in corresponding normal thyroid tissues in the local and TCGA cohorts. This downregulation was associated with unfavorable clinicopathological features, including histological type, high tumor stage, aggressive lymph node metastasis (LNM), and advanced clinical stage. In addition, logistic analyses revealed that the reduced expression of CDH16 can aggravate the risk of LNM in PTC. Bioinformatics analysis indicated that the co-expressed CDH16 genes mainly participated in signaling the cancer-related pathways.Conclusion: CDH16 is involved in PTC progression and acts as an LNM-related gene in PTC.Keywords: CDH16, papillary thyroid cancer, lymph node metastasis, co-expression, mechanismhttps://www.dovepress.com/downregulation-of-cdh16-in-papillary-thyroid-cancer-and-its-potential--peer-reviewed-article-CMARcdh16papillary thyroid cancerlymph node metastasisco-expressionmechanism
spellingShingle Li P
Wu Q
Sun Y
Pan X
Han Y
Ye B
Zhang Y
Dong J
Zheng Z
Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
Cancer Management and Research
cdh16
papillary thyroid cancer
lymph node metastasis
co-expression
mechanism
title Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
title_full Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
title_fullStr Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
title_full_unstemmed Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
title_short Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis
title_sort downregulation of cdh16 in papillary thyroid cancer and its potential molecular mechanism analysed by qrt pcr tcga and in silico analysis
topic cdh16
papillary thyroid cancer
lymph node metastasis
co-expression
mechanism
url https://www.dovepress.com/downregulation-of-cdh16-in-papillary-thyroid-cancer-and-its-potential--peer-reviewed-article-CMAR
work_keys_str_mv AT lip downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT wuq downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT suny downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT panx downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT hany downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT yeb downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT zhangy downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT dongj downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis
AT zhengz downregulationofcdh16inpapillarythyroidcanceranditspotentialmolecularmechanismanalysedbyqrtpcrtcgaandinsilicoanalysis